Early menopause means menopause occurring before age 45. Premature ovarian insufficiency, or POI, describes loss of normal ovarian activity before 40. Although these terms are sometimes used interchangeably with premature menopause, POI can involve intermittent ovarian activity and is not always equivalent to a permanent, complete end of ovarian function. [1] [2]
This distinction matters because the care conversation goes beyond hot flushes. It can include fertility, contraception, bone and cardiovascular health, emotional wellbeing and the role of hormone replacement. Suspected early menopause or POI should be assessed rather than diagnosed from an online quiz or assumed to be ordinary stress.
What signs should prompt an appointment?
A sustained change in periods, missed periods or periods stopping before the usual menopause age deserves discussion. Hot flushes, night sweats, vaginal dryness, disrupted sleep and changes in sexual comfort may add to the picture, but not everyone has obvious symptoms. [1]
There are other explanations for absent or irregular periods, including pregnancy, hormonal contraception, thyroid problems, changes in energy intake and some other medical conditions. A clinician considers these possibilities rather than treating one missed period as proof that ovarian function has ended.
Book an appointment when the pattern is unusual for you, especially when pregnancy or fertility is a concern. You do not have to wait until symptoms become severe. Bring approximate dates, details of contraception and medicines, and any family history of early menopause. Following cancer treatment or ovarian surgery, discuss expected ovarian effects directly with the treating team.
How are early menopause and POI diagnosed?
Assessment combines menstrual history, age, symptoms, medical background and appropriate investigations. Hormone testing has a more important role in suspected POI than in a typical menopause presentation after 45. The exact diagnostic process and need to repeat tests depend on the guideline and clinical circumstances. [3]
It is reasonable to ask which criteria your clinician is using. International POI guidance and some national pathways differ in how they use repeat follicle-stimulating hormone, or FSH, testing. Hormonal treatment may conceal the menstrual pattern or affect results, so do not stop it without a plan from the clinician.
A diagnosis should not rest solely on an anti-Mullerian hormone result from a fertility or wellness package. AMH can be useful in particular settings, but it is not a standalone explanation of every menstrual change. Ask what has been established, what remains uncertain and whether specialist reproductive or endocrine advice would help.
Why can ovarian insufficiency happen?
POI can be associated with genetic factors, autoimmune conditions, surgery or treatment such as chemotherapy. Sometimes no clear cause is identified. A lack of a definite cause does not mean the symptoms are imagined or that you caused the problem through lifestyle choices. [2]
The investigations recommended after diagnosis depend on the circumstances. A specialist may discuss relevant genetic or autoimmune testing and whether findings could affect relatives or future care. Before agreeing, ask what the test could show, what it cannot establish, and whether counselling is available for unexpected results.
Avoid claims that a supplement, detox or stress programme can reliably restore ovarian function. A provider should distinguish symptom support from evidence of restored fertility or ovarian activity. Commercial language about “ovarian rejuvenation” should not replace a careful discussion of uncertainty, risks, cost and reproductive options. [4]
Why hormone treatment is a different conversation here
For POI or early menopause, replacing missing hormones may be considered not only for symptom relief but also for longer-term health. Guidelines generally recommend hormone therapy until the usual menopause age when no contraindication applies, with individual review. This is a different context from starting HRT for the first time much later in life. [3]
The choice can involve HRT or, for some people, a combined hormonal contraceptive. These do not serve identical purposes. Contraceptive needs, medical history, bleeding preferences and the desired treatment outcomes all matter. A clinician should explain why a particular option is appropriate rather than simply prescribe the same regimen used for every midlife patient.
When systemic oestrogen is used by someone with a uterus, adequate progestogen is generally needed to protect the womb lining. Previous cancer or another important medical condition can change the balance and require specialist input. Do not start borrowed hormones, change doses independently or omit part of a combined regimen. [5]
Fertility: make room for both facts and feelings
POI can reduce fertility, but intermittent ovarian activity means it is not always the same as absolute infertility. Individual counselling is important whether you hope to conceive, wish to avoid pregnancy or are not ready to decide. Neither a reassuring anecdote nor a pessimistic online forecast can predict your personal outcome. [2]
A reproductive specialist can discuss realistic options, including fertility treatments where appropriate. The available choices depend on your history, prior fertility preservation, local services and personal preferences. No treatment should be presented as a guaranteed way to restore your own ovarian function. [4]
The emotional impact may include grief, anger, relief at having an explanation, or uncertainty. You do not need to make every reproductive decision at the first appointment. Ask for information in writing and time to consider it, while also asking whether any aspect is time-sensitive. Support should be available without assuming that parenthood is everyone’s goal.
Contraception still needs explicit attention
HRT is not contraception. When pregnancy is not wanted and ovarian activity may still occur, ask which contraceptive method is suitable and how it fits with the hormone plan. A diagnosis of POI does not automatically make pregnancy prevention irrelevant. [3]
Different combinations require different clinical decisions. For example, a method chosen to prevent pregnancy may have a separate role in bleeding management, while another medicine is prescribed for symptoms. Do not assume that any progesterone-containing product automatically provides all the protection you need.
Ask the clinician to write down the purpose of each medicine and when it needs review or replacement. This is particularly useful when prescriptions come from more than one service. Our contraception guide explains the distinction between preventing pregnancy and protecting the womb lining during HRT.
Bone and cardiovascular health
Earlier loss of ovarian hormone exposure can affect longer-term bone and cardiovascular health. A care plan may include assessment of bone density and conventional cardiovascular risk factors, with follow-up determined by findings and treatment. These discussions should be proportionate rather than framed as an inevitable decline. [1] [3]
Bring a history of fractures, smoking, relevant medicines, family cardiovascular disease and any previous bone scans. Exercise, nutrition and avoiding tobacco can support health, but they do not automatically replace indicated hormone or other medical treatment. Conversely, taking HRT does not remove the value of ordinary preventive care.
Ask what monitoring is actually needed and why. Repeating broad commercial panels without a decision attached can create cost and anxiety. A focused plan is easier to follow: identify the health question, agree the appropriate assessment, and know who will act on the result. See bone health and heart health for more context.
Sexual comfort and emotional wellbeing
Vaginal dryness or pain can affect intimacy regardless of age or relationship status. Local treatment, practical support and assessment for other causes may help. Raising the issue does not commit you to a particular treatment or make sexual activity a requirement of recovery. [6]
A younger person may find that ordinary menopause messaging does not reflect their experience. Friends may be discussing pregnancy while they are processing uncertain fertility or a new diagnosis. A clinician should make room for that context rather than assume standard midlife advice is sufficient.
Counselling, peer support or mental-health treatment can be useful depending on need. Significant depression, anxiety or thoughts of self-harm require appropriate assessment, not simply a promise that hormones will resolve everything. You can seek emotional support alongside medical treatment without having to prove that one explanation is more important than the other.
A useful distinction in a follow-up conversation is between confirming the diagnosis and identifying its cause. The diagnosis may be clear even when investigations do not reveal why ovarian activity changed. Ask which unanswered questions affect treatment now and which are mainly relevant to fertility counselling or relatives. This can help prevent an open-ended search for a cause from delaying practical support. [3]
What a good follow-up plan should contain
A written plan should identify the diagnosis or working diagnosis, treatment purpose, contraceptive advice, any further investigations and the next review. Ask whom to contact about unexpected bleeding, adverse effects, missed treatment or a change in pregnancy plans. Know which professional coordinates the different parts.
If treatment is declined or contraindicated, the discussion should still cover symptom support, bone health and longer-term care. An informed choice not to take one medicine is not a reason to lose access to follow-up. Equally, discomfort with uncertainty is not a reason to accept an unproven expensive programme.
Use the appointment planner to separate immediate concerns from questions that need specialist input. Early menopause and POI deserve careful, individual care. The aim is not to force your experience into a standard menopause narrative, but to support your health and decisions with clear information over time.
Sources you can inspect
- NHS: Early or premature menopause
- NICHD, NIH: Primary ovarian insufficiency
- American Society for Reproductive Medicine: Evidence-based guideline: premature ovarian insufficiency (2024)
- NICHD, NIH: Treatments for primary ovarian insufficiency
- NHS: Types of HRT
- The Menopause Society: Sexual health
Sources consulted 21 September 2026. This date records source consultation, not individual medical review. Provider descriptions are self-published and require direct verification.